Marleen Bakker

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

Mendelian Disorder, Genetics, Ivacaftor Combination Regimen +2

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Gitte Berkers, Peter van Mourik, Annelotte M. Vonk et al. · Cell Reports · 2019 · 300 citations · Full text

The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy

M. Stegeman, Marissa Louwen, Jacobus van der Velden et al. · Gynecologic Oncology · 2007 · 154 citations

Surgical Oncology, Gynecological Surgery, Cervical Cancer +8

Clinical Manifestations of Patients With Intraocular Inflammation and Positive QuantiFERON–TB Gold In-Tube Test in a Country Nonendemic for Tuberculosis

Rina La Distia Nora, Mirjam E. J. van Velthoven, Ninette H. ten Dam‐van Loon et al. · American Journal of Ophthalmology · 2013 · 91 citations

Pulmonary Tuberculosis, Ophthalmology, Country Nonendemic +6

Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients

Rogier A.S. Hoek, Marthe S. Paats, Suzan D. Pas et al. · Scandinavian Journal of Infectious Diseases · 2012 · 89 citations

Epidemiology, Molecular Diagnostic Techniques, Virus Epidemiology +14